The relationships between sponsors, CROs and study sites

can present many challenges in clinical trial planning and

execution. Any relationship can be complicated, but the way

in which these parties interact with each other can have a

significant impact on the overall success of a clinical trial.

In this article, Jeffrey Zucker, Vice President of Feasibility

and Recruitment Optimization at Worldwide Clinical

Trials, offers strategies for establishing and maintaining

key relationships, and advice on how sponsors and CROs

can build and enhance site partnerships to optimise study

execution from trial start-up and recruitment through to

implementation.